Detailed price information for Cellectis S.A. ADR (CLLS-Q) from The Globe and Mail including charting and trades.

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the second quarter ended ...

Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific ...

Negotiations for the sixth U.S. FDA device user fee agreement (MDUFA VI) are officially underway, and the Aug. 4 meeting ...

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HyHub TM and HyHub TM Duo, devices for patients 17 years of age and older ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials ...

Shanghai, China –August 6, 2025 – Everest Medicines (HKEX 1952,“Everest”, or the Company), a biopharmaceutical company focused on the discovery, cl ...

Service on the 7 train is slowly resuming between Manhattan and Queens after a brake issue partially suspended trains during the Wednesday morning commute.